This brand name is authorized in Mexico.
The drug METADIEMIL contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
05D48LUM4Z - DIHYDROERGOCRISTINE
|
2
|
UNII
ZH516LNZ10 - PIRACETAM
|
|
Piracetam’s mode of action in cortical myoclonus is as yet unknown. Piracetam exerts its haemorrheological effects on the platelets, red blood cells, and vessel walls by increasing erythrocyte deformability and by decreasing platelet aggregation, erythrocyte adhesion to vessel walls and capillary vasospasm. |
|
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| MX | Comisión Federal para la Protección contra Riesgos Sanitarios | 244M2007 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.